Two batches of IPS melatonin 10mg capsules recalled

Two batches of IPS melatonin 10mg capsules recalled

July 19 2018 IPS Specials is recalling two batches of its melatonin 10mg capsules, due to an...

Government considering how to implement changes to specials reimbursement

Government considering how to implement changes to specials reimbursement

May 25 2018 The government is still considering how to implement legislation passed last year...

Price of specials medicines to come under further scrutiny

Price of specials medicines to come under further scrutiny

May 9 2018 The Government says that new regulations will strengthen controls around pricing for...

Specials Drug Tariff updated for February

Specials Drug Tariff updated for February

February 2 2018 The Drug Tariffs relating to specials medicines has been updated for the February...

Special Products becomes Veriton Pharma

Special Products becomes Veriton Pharma

October 3 2017 Special Products Ltd has changed its name to Veriton Pharma Limited, to better...

  • Two batches of IPS melatonin 10mg capsules recalled

    Two batches of IPS melatonin 10mg capsules recalled

    Thursday, 19 July 2018 10:25
  • Government considering how to implement changes to specials reimbursement

    Government considering how to implement changes to specials reimbursement

    Tuesday, 29 May 2018 12:30
  • Price of specials medicines to come under further scrutiny

    Price of specials medicines to come under further scrutiny

    Wednesday, 09 May 2018 15:21
  • Specials Drug Tariff updated for February

    Specials Drug Tariff updated for February

    Friday, 02 February 2018 14:10
  • Special Products becomes Veriton Pharma

    Special Products becomes Veriton Pharma

    Tuesday, 03 October 2017 18:03

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a westminster imageMay 25 2018

The government is still considering how to implement legislation passed last year that could change the way specials medicines are reimbursed. 

Powers given under the Health Service Medical Supplies (Costs) Act 2017 allow the Government to reimburse specials dispensed in primary care “in different ways such as considering quotes of suppliers and not reimbursing pharmacies at all if for example they have been provided the medicine by a central service,” health minister Lord O'Shaughnessy said.

“The Government is considering how to implement its powers in the 2017 Act and any proposals to implement changes will be subject to consultation with relevant stakeholders.”

Further regulations are being drafted around the provision of information (including pricing) relating to products used in the NHS. The regulations are expected to come into force later this summer and will “include requirements in relation to special medicinal products which will ensure that the Government obtains information from all manufacturers and importers. 

“This information will make the reimbursement arrangements for the most commonly used special medicinal products more robust. However, where there are concerns about an individual price, it will also enable us to request from suppliers’ information on the costs of supplying a product.”

Lord O'Shaughnessy made the comments in a written response to questions raised by Baroness Masham of Ilton.

Link:
Hansard: ‘Health Service Medical Supplies (Costs) Act 2017: Written question - HL7946’ 

Specials News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...